KAINOS Laboratories, Inc. announced a private placement of 230,000 common shares at a price of JPY 1,089 per share for gross proceeds of JPY 250,470,000 on February 25, 2022. The transaction will included participation from new investor, Sysmex Corporation for 5.17% stake in the company. The company expects to close the transaction on March 14, 2022.

The method of private placement is third part allotment. The estimated issue expenses is JPY 1,000,000. The company will pay the issue expenses for the preparation of documents such as the Securities Registration Statement, etc.

The transaction has been approved by the board of directors.